For Immediate Release
Baltimore MD | April 29, 2020
Maryland Development Center portfolio company, NeuroSonics Medical, has executed a research agreement with the Johns Hopkins University as part of their recent National Science Foundation STTR Phase I award. Dr. Nao Gamo, co-founder and CEO of NeuroSonics Medical, will work with Dr. Amir Manbachi, Assistant Professor of Neurosurgery and Biomedical Engineering at the Johns Hopkins University, to develop a focused ultrasound device for minimally invasive neurosurgery. NeuroSonics Medical’s overall vision is to develop a pipeline of products that use ultrasound to safely and effectively treat range of diseases.
“Congratulations to the NeuroSonics team for this important accomplishment. The NeuroSonics technology offers real promise as a treatment option for a variety of conditions. Dr. Gamo and Dr. Manbachi are a great team to develop and realize the potential of this exciting technology.,” said Dr. Gil Blankenship, co-founder and CEO of MDC.
About Maryland Development Center
The Maryland Development Center is a startup studio created to commercialize intellectual property developed in Maryland’s rich research enterprises. Since its founding MDC has explored dozens of technologies, created 7 companies, and filed numerous patents. Maryland has the largest federal research budget in the United States; MDC was created to help realize some of the commercial value of the extraordinary research programs at the State’s great universities and laboratories.